Invention Grant
US08426448B2 1,5-diphenyl-pyrrolidin-2-one compounds as CB-1 ligands
失效
1,5-二苯基 - 吡咯烷-2-酮化合物作为CB-1配体
- Patent Title: 1,5-diphenyl-pyrrolidin-2-one compounds as CB-1 ligands
- Patent Title (中): 1,5-二苯基 - 吡咯烷-2-酮化合物作为CB-1配体
-
Application No.: US12935593Application Date: 2009-04-02
-
Publication No.: US08426448B2Publication Date: 2013-04-23
- Inventor: Jingdan Hu
- Applicant: Jingdan Hu
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent R. Craig Tucker
- International Application: PCT/US2009/039254 WO 20090402
- International Announcement: WO2009/131814 WO 20091029
- Main IPC: C07D401/12
- IPC: C07D401/12 ; A61K31/4439
Abstract:
CB-1 receptor inverse agonist compounds of Formula and pharmaceutical compositions for the treatment of obesity or cognitive impairment associated with schizophrenia.
Public/Granted literature
- US20110028520A1 1,5-DIPHENYL-PYRROLIDIN-2-ONE COMPOUNDS AS CB-1 LIGANDS Public/Granted day:2011-02-03
Information query
